Pharmaceutical Price Controls in the Oecd Countries
Pharmaceutical Price Controls in OECD Countries
Implications for U.S. Consumers, Pricing, Research and Development, and Innovation
U.S. Department of Commerce International Trade Administration
The International Trade Administration (ITA) has as its mission the creation of economic opportunity for U.S. workers and firms by promoting international trade, opening foreign markets, ensuring compliance with trade laws and agreements, and supporting U.S. commercial interests at home and abroad. To learn more about the ITA, write to: International Trade Administration, Office of Public Affairs, U.S. Department of Commerce, Washington, DC 20230, or visit the ITA’s Internet site at www.ita.doc.gov.
Pharmaceutical Price Controls in OECD Countries
Implications for U.S. Consumers, Pricing, Research and Development, and Innovation
U.S. Department of Commerce International Trade Administration
Washington, DC December 2004
Printed on recycled paper. Federal Recycling Program
The full text of this report is available on the International Trade Administration’s Internet site at www.ita.doc.gov/drugpricingstudy. It is also available for purchase as a paper, microfiche, or electronic reprint from the National Technical Information Service, 5285 Port Royal Road, Springfield, VA 22161; www.ntis.gov.
ii U.S. Department of Commerce, International Trade Administration
Contents
Executive Summary vii 1 Introduction 1 2 Drug Price Regulations in Selected OECD Countries—An Overview of the Issues 3 3 Price And Revenue Effects 10 4 Impact of Deregulating Prices on Research and Development, Innovation, and Consumers 25 Appendix A: Technical Methodology 35 Appendix B: Drug Pricing Study—Federal Register Notice Responses 49 Appendix C: Report on Pharmaceutical Markets in 11 OECD Countries 57
Pharmaceutical Price Controls in OECD Countries iii
iv U.S. Department of Commerce, International Trade Administration
Abbreviations and Acronyms
ANDA ANDS ATC ATP
Implications for U.S. Consumers, Pricing, Research and Development, and Innovation
U.S. Department of Commerce International Trade Administration
The International Trade Administration (ITA) has as its mission the creation of economic opportunity for U.S. workers and firms by promoting international trade, opening foreign markets, ensuring compliance with trade laws and agreements, and supporting U.S. commercial interests at home and abroad. To learn more about the ITA, write to: International Trade Administration, Office of Public Affairs, U.S. Department of Commerce, Washington, DC 20230, or visit the ITA’s Internet site at www.ita.doc.gov.
Pharmaceutical Price Controls in OECD Countries
Implications for U.S. Consumers, Pricing, Research and Development, and Innovation
U.S. Department of Commerce International Trade Administration
Washington, DC December 2004
Printed on recycled paper. Federal Recycling Program
The full text of this report is available on the International Trade Administration’s Internet site at www.ita.doc.gov/drugpricingstudy. It is also available for purchase as a paper, microfiche, or electronic reprint from the National Technical Information Service, 5285 Port Royal Road, Springfield, VA 22161; www.ntis.gov.
ii U.S. Department of Commerce, International Trade Administration
Contents
Executive Summary vii 1 Introduction 1 2 Drug Price Regulations in Selected OECD Countries—An Overview of the Issues 3 3 Price And Revenue Effects 10 4 Impact of Deregulating Prices on Research and Development, Innovation, and Consumers 25 Appendix A: Technical Methodology 35 Appendix B: Drug Pricing Study—Federal Register Notice Responses 49 Appendix C: Report on Pharmaceutical Markets in 11 OECD Countries 57
Pharmaceutical Price Controls in OECD Countries iii
iv U.S. Department of Commerce, International Trade Administration
Abbreviations and Acronyms
ANDA ANDS ATC ATP